Drug record
What four public record sets show for venlafaxine. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.071 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $160.0 million | Details |
| FDA recall records | 29 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Venlafaxine Hcl 25 Mg Tablet: pharmacies pay about $0.071 each, or $2.14 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| VENLAFAXINE BES ER 112.5 MG TB | Generic | $6.31 per each | $189.38 | Oct 21, 2026 |
| VENLAFAXINE HCL 100 MG TABLET | Generic | $0.120 per each | $3.61 | Oct 21, 2026 |
| VENLAFAXINE HCL 25 MG TABLET | Generic | $0.071 per each | $2.14 | Oct 21, 2026 |
| VENLAFAXINE HCL 37.5 MG TABLET | Generic | $0.074 per each | $2.22 | Oct 21, 2026 |
| VENLAFAXINE HCL 50 MG TABLET | Generic | $0.085 per each | $2.55 | Oct 21, 2026 |
| VENLAFAXINE HCL 75 MG TABLET | Generic | $0.086 per each | $2.58 | Oct 21, 2026 |
| VENLAFAXINE HCL ER 150 MG CAP | Generic | $0.122 per each | $3.67 | Nov 11, 2026 |
| VENLAFAXINE HCL ER 150 MG TAB | Generic | $0.226 per each | $6.77 | Oct 21, 2026 |
| VENLAFAXINE HCL ER 225 MG TAB | Generic | $0.474 per each | $14.22 | Oct 21, 2026 |
| VENLAFAXINE HCL ER 37.5 MG CAP | Generic | $0.079 per each | $2.37 | Nov 11, 2026 |
| VENLAFAXINE HCL ER 37.5 MG TAB | Generic | $0.305 per each | $9.15 | Oct 21, 2026 |
| VENLAFAXINE HCL ER 75 MG CAP | Generic | $0.080 per each | $2.40 | Nov 11, 2026 |
| VENLAFAXINE HCL ER 75 MG TAB | Generic | $0.290 per each | $8.70 | Oct 21, 2026 |
| EFFEXOR XR 150 MG CAPSULE | Brand | $21.62 per each | $648.51 | Oct 21, 2026 |
| EFFEXOR XR 37.5 MG CAPSULE | Brand | $17.72 per each | $531.63 | Oct 21, 2026 |
| EFFEXOR XR 75 MG CAPSULE | Brand | $19.81 per each | $594.38 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $160.0 million for the 4 products below. That is down 29% from $226.4 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Venlafaxine HCl ER Venlafaxine HCl | $118.5 million | 993,473 | $21.85 | $119.30 | $166.4 million |
| Effexor XR Venlafaxine HCl | $23.8 million | 2,814 | $1,398.74 | $8,448.63 | $30.5 million |
| Venlafaxine HCl Venlafaxine HCl | $17.0 million | 167,368 | $23.17 | $101.30 | $29.5 million |
| Venlafaxine Besylate ER Venlafaxine Besylate | $758,732 | 745 | $286.53 | $1,018.43 | — |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 29 recall records that name venlafaxine in the product description (2 Class I · 22 Class II · 5 Class III).
Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01.
Reason: Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
Reason: Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and b)1000-count bottles (NDC 68382-034-10), Rx only, Mfg. by: Zydus Lifesciences Ltd. Ahmedabad, India; Dist. by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534
Reason: Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.
Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Major Pharmaceutical 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, USA, NDC 0904-7075-61, UPC code: 309047075614
Reason: Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.
Venlafaxine Tablets, USP 50 mg*, 100 Tablets Manufactured for Northstar Rx LLC Memphis, TN 38141 Manufactured by: ALKALOIDA Chemical Company Zrt. 4440 Tiszavasvari, Kabay Janos u.29.Hungary. Product of India NDC 16714-657-01
Reason: Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
Reason: Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 072 India, NDC 65862-527-30
Reason: Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted capsules.
Venlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 68382-036-06), b) 90-count bottles (NDC 68382-036-16), and c) 1000-count bottles, (NDC 68382-036-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.
Reason: Failed Dissolution Specifications: out of specification dissolution results in retained samples
Venlafaxine Hydrochloride Extended-Release Capsules, 150 mg, a) 30 capsules per bottle, NDC # 60429-123-30, b) 90 capsules per bottle, NDC # 60429-123-90, Rx Only, GSMS.
Reason: Failed Dissolution Specifications: Out-of-specification results in retained sample.
Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.
Reason: Failed Dissolution Specifications: out of specification dissolution results in retained samples
Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per bottle, Rx Only, GSMS, NDC # 60429-122-90
Reason: Failed Dissolution Specifications: Out-of-specification results in retained sample.
Venlafaxine 75 mg Tablet, Compare to Effexor 75 mg Tablet, a) 30-count bottle (NDC 636290-3324-2), b) 100-count bottle (NDC 63629-3324-6), Rx Only, Manufactured by Teva Pharmaceuticals USA, Inc. Packaged by Bryant Ranch.
Reason: Labeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as the immediate release formulation.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for venlafaxine. This page is public-record information, not medical advice.